1. Home
  2. VC vs BLTE Comparison

VC vs BLTE Comparison

Compare VC & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VC
  • BLTE
  • Stock Information
  • Founded
  • VC 2000
  • BLTE 2018
  • Country
  • VC United States
  • BLTE United States
  • Employees
  • VC N/A
  • BLTE N/A
  • Industry
  • VC Auto Parts:O.E.M.
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • VC Consumer Discretionary
  • BLTE Health Care
  • Exchange
  • VC Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • VC 2.6B
  • BLTE 2.1B
  • IPO Year
  • VC 2000
  • BLTE 2022
  • Fundamental
  • Price
  • VC $85.49
  • BLTE $63.44
  • Analyst Decision
  • VC Buy
  • BLTE Strong Buy
  • Analyst Count
  • VC 17
  • BLTE 4
  • Target Price
  • VC $128.40
  • BLTE $89.00
  • AVG Volume (30 Days)
  • VC 299.7K
  • BLTE 63.5K
  • Earning Date
  • VC 10-24-2024
  • BLTE 11-12-2024
  • Dividend Yield
  • VC N/A
  • BLTE N/A
  • EPS Growth
  • VC 243.41
  • BLTE N/A
  • EPS
  • VC 18.51
  • BLTE N/A
  • Revenue
  • VC $3,917,000,000.00
  • BLTE N/A
  • Revenue This Year
  • VC $1.04
  • BLTE N/A
  • Revenue Next Year
  • VC $4.61
  • BLTE N/A
  • P/E Ratio
  • VC $4.62
  • BLTE N/A
  • Revenue Growth
  • VC N/A
  • BLTE N/A
  • 52 Week Low
  • VC $84.10
  • BLTE $31.01
  • 52 Week High
  • VC $130.10
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • VC 32.32
  • BLTE 43.10
  • Support Level
  • VC $89.63
  • BLTE $60.00
  • Resistance Level
  • VC $94.60
  • BLTE $76.87
  • Average True Range (ATR)
  • VC 3.13
  • BLTE 4.51
  • MACD
  • VC -0.89
  • BLTE -0.65
  • Stochastic Oscillator
  • VC 10.24
  • BLTE 20.39

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated advanced driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: